Insider Trading activities of Acorda Therapeutics Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acorda Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acorda Therapeutics Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Acorda Therapeutics Inc since 2005. The reporting company's ticker symbol is ACOR. The reporting company's CIK number is 1008848.
The total value of stock buying since 2005 is $17,199,472.
The total value of stock sales since 2005 is $127,471,877.
The total value of stock option exercises since 2005 is $17,127,161.


 1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Acorda Therapeutics Inc insiders (ACOR) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-12-01 Cohen Ron (President and CEO) Sale 16,500 22.92 378,180
2011-12-01 Lawrence David (Chief Financial Officer) Sale 9,896 22.92 226,816
2011-06-08 Cohen Ron (President and CEO) Sale 12,000 30.87 370,440
2011-05-26 Cohen Ron (President and CEO) Sale 60,000 32.58 1,954,800
2011-05-26 Cohen Ron (President and CEO) Option Ex 60,000 2.60 156,000
2011-05-20 Randall Lorin (Director) Sale 2,500 31.60 79,000
2011-05-20 Randall Lorin (Director) Option Ex 2,500 6.00 15,000
2011-04-18 Cohen Ron (President and CEO) Sale 60,000 28.24 1,694,400
2011-04-18 Cohen Ron (President and CEO) Option Ex 60,000 2.60 156,000
2011-03-03 Panem Sandra Phd (Director) Sale 19,867 22.28 442,636
2011-03-01 Panem Sandra Phd (Director) Sale 109,188 21.00 2,292,948
2011-01-10 Randall Lorin (Director) Sale 5,000 30.00 150,000
2011-01-10 Randall Lorin (Director) Option Ex 5,000 6.00 30,000
2010-12-01 Sabella Lauren M (Exec. VP-Commercial Dvlpmnt) Sale 3,933 26.53 104,342
2010-12-01 Wasman Jane (Exec VP, General Counsel & Sec) Sale 7,500 26.60 199,500
2010-12-01 Cohen Ron (President and CEO) Sale 15,000 26.64 399,675
2010-12-01 Lawrence David (Chief Financial Officer) Sale 10,905 26.62 290,291
2010-08-23 Cohen Ron (President and CEO) Option Ex 18,696 2.60 48,609
2010-08-11 Randall Lorin (Director) Sale 5,000 33.52 167,600
2010-08-11 Randall Lorin (Director) Option Ex 5,000 6.00 30,000
2010-08-09 Panem Sandra Phd (Director) Sale 15,000 35.02 525,300
2010-08-06 Panem Sandra Phd (Director) Sale 3,280 35.03 114,898
2010-08-05 Cohen Ron (President and CEO) Sale 55,000 36.18 1,989,900
2010-08-05 Cohen Ron (President and CEO) Option Ex 55,000 2.60 143,000
2010-08-05 Panem Sandra Phd (Director) Sale 196,720 36.03 7,087,821
2010-08-05 Rauscher Steven M (Director) Sale 30,000 36.21 1,086,300
2010-08-05 Rauscher Steven M (Director) Option Ex 30,000 8.14 244,200
2010-06-14 Panem Sandra Phd (Director) Sale 8,397 34.00 285,498
2010-03-12 Panem Sandra Phd (Director) Sale 8,394 35.02 293,915
2010-03-10 Lawrence David (Chief Financial Officer) Sale 12,000 34.16 409,955
2010-03-10 Lawrence David (Chief Financial Officer) Option Ex 12,000 8.14 97,680
2010-03-10 Panem Sandra Phd (Director) Sale 60,000 34.00 2,040,059
2010-03-09 Cohen Ron (President and CEO) Sale 19,000 33.73 640,775
2010-03-09 Cohen Ron (President and CEO) Option Ex 19,000 2.60 49,400
2010-03-08 Cohen Ron (President and CEO) Sale 19,000 33.15 629,850
2010-03-08 Cohen Ron (President and CEO) Option Ex 19,000 2.60 49,400
2010-03-02 Blight Andrew (Chief Scientifc Officer) Sale 4,173 32.21 134,408
2010-02-02 Blight Andrew (Chief Scientifc Officer) Sale 4,534 30.00 136,020
2010-02-02 Lawrence David (Chief Financial Officer) Sale 5,000 30.00 150,000
2010-02-02 Lawrence David (Chief Financial Officer) Option Ex 5,000 8.14 40,700
2010-01-22 Lawrence David (Chief Financial Officer) Sale 5,000 28.00 140,000
2010-01-22 Lawrence David (Chief Financial Officer) Option Ex 5,000 8.14 40,700
2009-12-16 Lawrence David (Chief Financial Officer) Sale 5,000 24.48 122,420
2009-12-16 Lawrence David (Chief Financial Officer) Option Ex 5,000 8.14 40,700
2009-12-01 Wasman Jane (Exec VP, General Counsel & Sec) Sale 5,000 24.50 122,505
2009-12-01 Blight Andrew (Chief Scientifc Officer) Sale 4,500 24.51 110,277
2009-12-01 Cohen Ron (President and CEO) Sale 8,500 24.50 208,292
2009-12-01 Lawrence David (Chief Financial Officer) Sale 7,466 24.51 182,961
2009-08-12 Randall Lorin (Director) Sale 10,000 23.58 235,799
2009-08-12 Randall Lorin (Director) Option Ex 10,000 6.00 60,000
2009-02-26 Panem Sandra Phd (Director) Sale 51,923 23.69 1,230,159
2009-02-26 Panem Sandra Phd (Director) Option Ex 1,923 2.60 4,999
2008-12-01 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,500 15.98 39,950
2008-12-01 Cohen Ron (President and CEO) Sale 4,000 15.89 63,560
2008-12-01 Lawrence David (Chief Financial Officer) Sale 4,134 16.54 68,376
2008-09-15 Panem Sandra Phd Sale 25,000 27.40 684,950
2008-09-08 Cohen Ron (President and CEO) Sale 25,000 29.68 743,517
2008-09-08 Cohen Ron (President and CEO) Option Ex 25,000 2.60 65,000
2008-07-08 Cohen Ron (President and CEO) Sale 25,000 31.27 781,654
2008-07-08 Cohen Ron (President and CEO) Option Ex 25,000 2.60 65,000
2008-06-13 Phillips Barclay A Sale 235,000 30.54 7,176,900
2008-06-12 Blight Andrew (Chief Scientific Officer) Sale 28,700 30.98 892,151
2008-06-12 Blight Andrew (Chief Scientific Officer) Option Ex 29,200 2.60 75,920
2008-06-12 Lawrence David (Chief Financial Officer) Sale 7,000 31.02 217,133
2008-06-12 Lawrence David (Chief Financial Officer) Option Ex 7,000 5.85 40,950
2008-06-11 Wasman Jane (Exec VP, General Counsel & Sec) Sale 3,500 31.61 110,621
2008-06-11 Wasman Jane (Exec VP, General Counsel & Sec) Option Ex 3,500 5.85 20,475
2008-06-11 Blight Andrew (Chief Scientific Officer) Sale 800 31.54 25,228
2008-06-11 Blight Andrew (Chief Scientific Officer) Option Ex 800 2.60 2,080
2008-06-05 Blight Andrew (Chief Scientific Officer) Sale 20,000 32.10 637,622
2008-06-05 Blight Andrew (Chief Scientific Officer) Option Ex 20,000 2.60 52,000
2008-06-05 Cohen Ron (President and CEO) Sale 50,000 31.88 1,586,650
2008-06-05 Cohen Ron (President and CEO) Option Ex 50,000 2.60 130,000
2008-06-04 Lawrence David (Chief Financial Officer) Sale 33,106 29.67 980,647
2008-06-04 Lawrence David (Chief Financial Officer) Option Ex 30,890 5.37 165,879
2008-05-12 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,425 19.16 46,458
2008-04-07 Blight Andrew (Chief Scientific Officer) Sale 3,586 18.39 65,953
2008-03-10 Blight Andrew (Chief Scientific Officer) Sale 4,000 17.93 71,704
2008-03-10 Cohen Ron (President and CEO) Sale 8,100 17.85 145,323
2008-03-10 Lawrence David (Chief Financial Officer) Sale 1,800 17.34 31,213
2008-02-19 Panem Sandra Phd Sale 83,000 21.50 1,784,500
2008-02-15 Blight Andrew (Chief Scientific Officer) Sale 4,487 23.38 104,915
2008-02-15 Blight Andrew (Chief Scientific Officer) Option Ex 4,487 2.60 11,666
2008-02-14 Panem Sandra Phd Sale 17,000 22.85 388,484
2008-02-11 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,425 22.99 55,753
2008-01-23 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,425 22.66 54,952
2008-01-23 Lawrence David (Chief Financial Officer) Sale 1,107 22.96 25,412
2008-01-15 Blight Andrew (Chief Scientific Officer) Sale 3,586 23.04 82,625
2008-01-14 Holman Wayne George (10% Owner) Sale 700,000 25.68 17,976,000
2008-01-11 Lawrence David (Chief Financial Officer) Sale 7,000 25.00 175,000
2008-01-11 Lawrence David (Chief Financial Officer) Option Ex 7,000 2.60 18,200
2007-12-27 Lawrence David (Chief Financial Officer) Sale 7,000 23.08 161,588
2007-12-27 Lawrence David (Chief Financial Officer) Option Ex 7,000 2.60 18,200
2007-12-21 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,425 20.56 49,850
2007-12-21 Lawrence David (Chief Financial Officer) Sale 1,107 20.57 22,767
2007-12-10 Blight Andrew (Chief Scientific Officer) Sale 4,000 20.38 81,504
2007-12-10 Cohen Ron (President and CEO) Sale 8,000 20.43 163,448
2007-12-10 Lawrence David (Chief Financial Officer) Sale 1,800 20.40 36,716
2007-11-21 Lawrence David (Chief Financial Officer) Sale 1,003 17.15 17,201
2007-11-15 Blight Andrew (Chief Scientific Officer) Sale 5,865 18.27 107,153
2007-11-12 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,425 18.76 45,497
2007-10-23 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,425 20.13 48,817
2007-10-23 Lawrence David (Chief Financial Officer) Sale 1,004 20.13 20,211
2007-10-15 Blight Andrew (Chief Scientific Officer) Sale 3,366 20.24 68,134
2007-10-15 Blight Andrew (Chief Scientific Officer) Option Ex 4,487 2.60 11,666
2007-09-26 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,425 18.79 45,563
2007-09-26 Lawrence David (Chief Financial Officer) Sale 2,008 18.77 37,682
2007-09-12 Lawrence David (Chief Financial Officer) Sale 2,007 15.98 32,075
2007-09-10 Blight Andrew (Chief Scientific Officer) Sale 4,000 16.05 64,191
2007-09-10 Cohen Ron (President and CEO) Sale 8,000 16.16 129,271
2007-08-17 Blight Andrew (Chief Scientific Officer) Sale 3,044 18.05 54,944
2007-08-17 Blight Andrew (Chief Scientific Officer) Option Ex 6,410 2.60 16,666
2007-08-14 Cohen Ron (President and CEO) Sale 26,000 16.95 440,570
2007-08-13 Cohen Ron (President and CEO) Sale 26,000 16.74 443,034
2007-08-10 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,425 16.99 41,205
2007-08-10 Cohen Ron (President and CEO) Sale 26,000 17.00 441,973
2007-08-09 Cohen Ron (President and CEO) Sale 26,000 17.77 462,149
2007-07-02 Fisher Mary (Chief Operating Officer) Sale 7,500 17.69 132,690
2007-06-15 Lawrence David (Chief Financial Officer) Sale 2,007 18.48 37,085
2007-06-15 Panem Sandra Phd Sale 23,708 18.48 438,171
2007-06-12 Blight Andrew (Chief Scientific Officer) Sale 500 31.05 15,525
2007-06-08 Blight Andrew (Chief Scientific Officer) Sale 3,040 18.50 56,240
2007-06-08 Panem Sandra Phd Sale 120,000 18.50 2,220,000
2007-06-01 Fisher Mary (Chief Operating Officer) Sale 7,500 19.65 147,352
2007-05-23 Lawrence David (Chief Financial Officer) Sale 883 24.20 21,371
2007-05-10 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,600 24.76 64,368
2007-05-01 Fisher Mary (Chief Operating Officer) Sale 7,500 24.29 182,160
2007-04-23 Lawrence David (Chief Financial Officer) Sale 883 24.05 21,236
2007-04-02 Fisher Mary (Chief Operating Officer) Sale 7,500 19.15 143,647
2007-03-22 Lawrence David (Chief Financial Officer) Sale 11,882 19.63 233,208
2007-03-01 Fisher Mary (Chief Operating Officer) Sale 7,500 20.95 157,095
2007-02-27 Panem Sandra Phd Sale 8,678 23.42 203,238
2007-02-23 Lawrence David (Chief Financial Officer) Sale 5,941 23.50 139,631
2007-02-12 Wasman Jane (Exec VP, General Counsel & Sec) Sale 2,600 21.46 55,798
2007-02-01 Fisher Mary (Chief Operating Officer) Sale 7,500 17.61 132,060
2007-01-23 Lawrence David (Chief Financial Officer) Sale 5,941 17.57 104,383
2007-01-03 Fisher Mary (Chief Operating Officer) Sale 7,500 15.50 117,226
2006-12-20 Lawrence David (Chief Financial Officer) Sale 5,941 15.82 93,986
2006-12-11 Blight Andrew (Chief Scientific Officer) Sale 2,500 16.93 42,314
2006-12-11 Lawrence David (Chief Financial Officer) Sale 1,365 17.00 23,210
2006-12-08 Young Wise Option Ex 641 1.56 999
2006-12-01 Fisher Mary (Chief Operating Officer) Sale 7,500 18.96 142,215
2006-12-01 Cohen Ron (President and CEO) Sale 7,591 18.96 143,940
2006-11-30 Blight Andrew (Chief Scientific Officer) Sale 641 19.52 12,509
2006-11-20 Lawrence David (Chief Financial Officer) Sale 5,058 18.72 96,347
2006-11-13 Pinney Mark R E Sale 15,713 14.94 234,689
2006-11-10 Wasman Jane (Exec VP, General Counsel & Sec) Sale 4,851 15.21 73,764
2006-11-07 Wasman Jane (Exec VP, General Counsel & Sec) Sale 15,000 15.40 232,639
2006-11-07 Blight Andrew (Chief Scientific Officer) Sale 30,000 15.48 464,735
2006-11-06 Wasman Jane (Exec VP, General Counsel & Sec) Sale 22,000 16.06 353,232
2006-11-06 Blight Andrew (Chief Scientific Officer) Sale 25,000 16.07 401,825
2006-11-06 Fisher Mary (Chief Operating Officer) Sale 40,000 16.07 642,840
2006-11-06 Lawrence David (Chief Financial Officer) Sale 14,853 16.07 238,658
2006-11-01 Cohen Ron (President & CEO) Sale 50,000 17.05 857,091
2006-10-16 Pinney Mark R E (Director) Sale 158,781 16.50 2,600,892
2006-10-16 Cohen Ron (President & CEO) Sale 50,000 16.39 820,825
2006-02-15 Panem Sandra Phd (Director) Buy 41,667 6.00 250,002
2006-02-15 Steinmetz Michael (Director) Buy 166,667 6.00 1,000,002
2006-02-15 Fleming Standish (Director) Buy 125,000 6.00 750,000
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ACOR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acorda Therapeutics Inc (symbol ACOR, CIK number 1008848) see the Securities and Exchange Commission (SEC) website.